GAVISCON DOUBLE ACTION LIQUID, SUSPENSION
Product details
Registration number: SIN14016P
Classification: General Sale List
Active ingredients:
- CALCIUM CARBONATE
- SODIUM ALGINATE
- SODIUM BICARBONATE
Strength:
- 325MG/10ML
- 500MG/10ML
- 213MG/10ML
Dosage form: SUSPENSION
Route: ORAL
Registrant: RECKITT BENCKISER (SINGAPORE) PTE LTD
ATC code: A02AD01
HSA approval date: 19 September 2011
Manufacturer(s): RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Manufacturing country/countries: UNITED KINGDOM
What are the HSA registration number and classification for GAVISCON DOUBLE ACTION LIQUID, SUSPENSION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14016P
Classification: General Sale List
What active ingredients and strength are recorded for GAVISCON DOUBLE ACTION LIQUID, SUSPENSION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CALCIUM CARBONATE
- SODIUM ALGINATE
- SODIUM BICARBONATE
Strength:
- 325MG/10ML
- 500MG/10ML
- 213MG/10ML
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for GAVISCON DOUBLE ACTION LIQUID, SUSPENSION?
According to the HSA dataset updated 7 August 2026:
Dosage form: SUSPENSION
Route: ORAL
Who is the recorded registrant for GAVISCON DOUBLE ACTION LIQUID, SUSPENSION?
According to the HSA dataset updated 7 August 2026:
Registrant: RECKITT BENCKISER (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for GAVISCON DOUBLE ACTION LIQUID, SUSPENSION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): RECKITT BENCKISER HEALTHCARE (UK) LIMITED
Manufacturing country/countries: UNITED KINGDOM
Where can I look up GAVISCON DOUBLE ACTION LIQUID, SUSPENSION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14016P or the exact product name GAVISCON DOUBLE ACTION LIQUID, SUSPENSION. The general register link does not preselect this product.
What are the source dates for this GAVISCON DOUBLE ACTION LIQUID, SUSPENSION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this GAVISCON DOUBLE ACTION LIQUID, SUSPENSION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14016P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)